1-1 of 1
Authors: Johannes Selbach
Journal Article
Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany Free
The Oncologist, Volume 22, Issue 2, February 2017, Pages 131–138, https://doi.org/10.1634/theoncologist.2016-0193
Published: 18 September 2017
